glp 1 and alzheimer's study GLP-1 improves the neuronal supportive ability of astrocytes in disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway Disappointing GLP-1 Results in Alzheimer's
Description
We present a 66-year-old female on semaglutide for obesity who developed AC within 72 hours post-CLN
He discovered GLP-1, which helped pave the way for transformative diabetes and obesity therapies, and he was an ASBMB member for 25 years.
Pfizer has made obesity, and the broader metabolic space, one of the core fixtures of its pipeline for the next decade
With a foreword by Dr Ellie Cannon
The product also includes
Understand GLP-1 medications for weight loss in Singapore, including Ozempic, Wegovy, Mounjaro and oral options
